PDGFRB and ovarian carcinoma: Even that we did not evaluate the activation of known downstream phosphorylation targets of the PDGFR pathway, the results demonstrate that as observed in other tumors such as osteosarcoma [45] and ovarian carcinoma [38], the blocking of this pathway could have therapeutical implications.